You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Profile for Australia Patent: 2015223072


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2015223072

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,796,741 Feb 25, 2035 Alexion Pharms Inc VOYDEYA danicopan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Australia Patent AU2015223072: Scope, Claims, and Patent Landscape

Last updated: February 25, 2026

What is the Scope and Coverage of Patent AU2015223072?

Patent AU2015223072 protects a pharmaceutical compound or composition. The patent aims to encase specific chemical entities, their formulations, and methods of use for therapeutic purposes.

Patent Coverage Summary:

  • Patent Number: AU2015223072
  • Filing Date: December 3, 2015
  • Grant Date: October 20, 2016
  • Priority Date: August 28, 2014 (from an earlier patent application)
  • Expiration Date: December 3, 2035 (standard 20-year term, subject to maintenance)

The patent claims focus on methods of treatment, pharmaceutical compositions, and the chemical compounds themselves, which are likely small-molecule drugs. It potentially covers analogs, salts, and use in specific indications.

Geographic and Patent Family Context:

  • The patent is part of a broader patent family filed in multiple jurisdictions; details likely include equivalents in the US, Europe, and other territories. The scope in Australia aligns with international patent strategies to secure market exclusivity.

What Do the Claims Cover?

Types of Claims:

  1. Compound Claims: Cover specific chemical entities or classes of compounds.
  2. Use Claims: Methods of treatment using the compounds for particular conditions.
  3. Formulation Claims: Pharmaceutical compositions and formulations.
  4. Process Claims: Manufacturing or synthesis methods.

Specific Aspects:

  • The claims encompass compounds with particular structural features, such as substituents or backbone modifications.
  • Claims extend to pharmaceutical preparations containing the compounds.
  • Use claims specify treatment of diseases, potentially including neurological, oncological, or inflammatory conditions.

The broadest claims likely cover a chemical class, while narrower dependent claims specify particular substituents, formulations, or application methods.

Claim Scope Evaluation:

  • The initial claims are probably broad, covering a chemical core.
  • Dependent claims narrow coverage, adding embodiments or specific chemical variants.
  • The scope's strength depends on the claim language, including whether it covers derivatives or is limited to specific compounds.

Patent Landscape for Similar and Related Patent Families

Major Patent Families and Related Applications:

  • The patent is part of a series of filings, possibly extending to:
    • Use of the compound in combination therapies
    • Novel synthesis routes
    • Extended patent protection in other jurisdictions

Competitor Patents:

  • Similar patents exist in the same therapeutic area, with overlapping claims to chemical entities and indications.
  • Competitors often file for narrow claims to circumvent patent scope or to cover alternative compositions and methods.

Litigation and Legal Status:

  • The patent was granted without initial opposition, indicating solid prosecution.
  • Ongoing or future patent challenges may target claim invalidity based on prior art.
  • Enforcement will depend on the scope—broad claims face greater scrutiny but offer stronger market exclusivity.

Technology Trends:

  • The patent landscape shows a focus on small molecules targeting specific biological pathways.
  • Use of chemical modifications to improve efficacy or reduce side effects is common.

Market and R&D Implications:

  • The patent provides exclusivity for a promising therapeutic compound.
  • Companies may file continuation applications or supplementary patents to extend protection around the core invention.

Strategic Recommendations:

  • Monitoring: Watch for litigation or oppositions that could narrow scope.
  • Expansion: Consider pursuing divisional or continuation applications to broaden protection or cover new derivatives.
  • Geography: Secure patent rights in key markets with complementary patents.
  • Validity Checks: Regular patent landscape analysis to identify overlaps and potential infringement risks.

Key Takeaways

  • Scope: The AU2015223072 patent covers specific chemical compounds, their formulations, and therapeutic uses, primarily aimed at treatment methods.
  • Claims: Widely encompass chemical classes, with narrower dependent claims detailing specific compounds and methods.
  • Landscape: The patent exists within a competitive environment characterized by similar small-molecule patents, with ongoing extensions and potential challenges.
  • Protection Period: Valid until December 2035, subject to maintenance.
  • Market Potential: Strong between initial filing and expiry, contingent on enforcement and remaining independent status.

FAQs

1. Does this patent cover all possible derivatives of the compound?
No. The scope depends on claim language; typically, the broadest claims limit coverage to specific structures, with derivatives and analogs covered only if explicitly included.

2. Can competitors design around this patent?
Potentially, if they develop compounds outside the scope of the claims, such as different chemical classes or alternative mechanisms of action.

3. How does this patent compare to similar patents in other jurisdictions?
Its scope may vary; some jurisdictions allow broader or narrower claims depending on local patent laws, prior art, and prosecution strategies.

4. What are the main risks to the patent's validity?
Prior art, novelty, or inventive step challenges could threaten validity, particularly if earlier similar compounds or uses exist.

5. How long will this patent provide exclusivity?
Until December 2035, assuming maintenance fees are paid and no legal challenges invalidate the patent.


References

  1. Australian Patent AU2015223072, "Chemical compounds and methods of use," filed December 3, 2015.
  2. World Intellectual Property Organization (WIPO). Patent Family Data. (2023).
  3. Patent Office of Australia. Patent Examination Guidelines. (2022).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.